First case of post-conception Verteporfin exposure: pregnancy and neonatal outcome.
De Santis
Marco
M
Telefono Rosso, Teratology Information Service, Department of Obstetrics and Gynaecology, Catholic University of the Sacred Heart, Rome, Italy. marcodesantis@rm.unicatt.it
Carducci
Brigida
B
De Santis
Lidia
L
Lucchese
Angela
A
Straface
Gianluca
G
D000328:Adult; D020256:Choroidal Neovascularization / Q000188:drug therapy*; D005260:Female; D005306:Fertilization; D006801:Humans; D007231:Infant, Newborn; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D011247:Pregnancy; D011256:Pregnancy Outcome; D000077362:Verteporfin
D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin